Vertus Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 21-12-2024
- Paid Up Capital ₹ 5.10 M
as on 21-12-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
as on 21-12-2024
- Revenue 281.64%
(FY 2023)
- Profit -4722.09%
(FY 2023)
- Ebitda -127.30%
(FY 2023)
- Net Worth -56.68%
(FY 2023)
- Total Assets -6.27%
(FY 2023)
About Vertus Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 5.10 M.
The company currently has active open charges totaling ₹2.00 Cr.
Nishita Nadella and Prasanth Manne serve as directors at the Company.
- CIN/LLPIN
U24110TG2020PTC143888
- Company No.
143888
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Sep 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vertus Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prasanth Manne  | Managing Director | 14-Sep-2020 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nishita Nadella | Director | 14-Sep-2020 | Current |
Financial Performance of Vertus Life Sciences.
Vertus Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 281.64% increase. The company also saw a substantial fall in profitability, with a 4722.09% decrease in profit. The company's net worth observed a substantial decline by a decrease of 56.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vertus Life Sciences?
Unlock access to Vertus Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Discovery Laboratories Private LimitedActive 21 years 13 daysNishita Nadella and Prasanth Manne are mutual person
Bionsys Life Sciences Private LimitedActive 4 years 1 monthNishita Nadella and Prasanth Manne are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 18 Nov 2021 | ₹2.00 Cr | Open |
How Many Employees Work at Vertus Life Sciences?
Vertus Life Sciences has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vertus Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vertus Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
